GB1113760A - Ophthalmic composition - Google Patents
Ophthalmic compositionInfo
- Publication number
- GB1113760A GB1113760A GB56491/66A GB5649166A GB1113760A GB 1113760 A GB1113760 A GB 1113760A GB 56491/66 A GB56491/66 A GB 56491/66A GB 5649166 A GB5649166 A GB 5649166A GB 1113760 A GB1113760 A GB 1113760A
- Authority
- GB
- United Kingdom
- Prior art keywords
- weight
- composition
- agent
- toxic
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 231100000252 nontoxic Toxicity 0.000 abstract 3
- 230000003000 nontoxic effect Effects 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 abstract 2
- JCIIKRHCWVHVFF-UHFFFAOYSA-N 1,2,4-thiadiazol-5-amine;hydrochloride Chemical compound Cl.NC1=NC=NS1 JCIIKRHCWVHVFF-UHFFFAOYSA-N 0.000 abstract 1
- BDOYKFSQFYNPKF-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;sodium Chemical compound [Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O BDOYKFSQFYNPKF-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960004926 chlorobutanol Drugs 0.000 abstract 1
- 230000000536 complexating effect Effects 0.000 abstract 1
- 239000008139 complexing agent Substances 0.000 abstract 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 abstract 1
- 229940020947 fluorescein sodium Drugs 0.000 abstract 1
- -1 hydrochloride) Chemical class 0.000 abstract 1
- 229960003502 oxybuprocaine Drugs 0.000 abstract 1
- CMHHMUWAYWTMGS-UHFFFAOYSA-N oxybuprocaine Chemical compound CCCCOC1=CC(C(=O)OCCN(CC)CC)=CC=C1N CMHHMUWAYWTMGS-UHFFFAOYSA-N 0.000 abstract 1
- OWWVHQUOYSPNNE-UHFFFAOYSA-N parethoxycaine Chemical compound CCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1 OWWVHQUOYSPNNE-UHFFFAOYSA-N 0.000 abstract 1
- 229960003899 parethoxycaine Drugs 0.000 abstract 1
- 229940096826 phenylmercuric acetate Drugs 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229960003981 proparacaine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 229960002372 tetracaine Drugs 0.000 abstract 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ophthalmic compositions, particularly for use with an applanation tonometer and in the location of foreign bodies in the eye, comprise (a), as local anaesthetic, 0.1 to 2% by weight of proparacaine, parethoxycaine, benoxinate, or tetracaine (in the form of a non-toxic, water-soluble salt, e.g. hydrochloride), (b) as disclosing agent, 0.05% to 0.3% by weight of fluorescein sodium and (c) 5 to 15% by weight of polyvinylpyrrolidone as complexing and solubilizing agent, the percentages being based on the total weight of the composition, and the balance of the composition being water and a non-toxic acid to bring the pH of the composition to 4.5 to 5.5. The non-toxic acid may be citric or preferably boric acid. The compositions may also contain an antimicrobial agent (e.g. chlorobutanol \sB phenyl mercuric acetate) and a chelating agent (e.g. disodium ethylene diamine tetra acetic acid).
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB56491/66A GB1113760A (en) | 1966-12-16 | 1966-12-16 | Ophthalmic composition |
| AU15852/66A AU412212B2 (en) | 1966-12-16 | 1966-12-29 | Ophthalmic composition |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB56491/66A GB1113760A (en) | 1966-12-16 | 1966-12-16 | Ophthalmic composition |
| AU15852/66A AU412212B2 (en) | 1966-12-16 | 1966-12-29 | Ophthalmic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1113760A true GB1113760A (en) | 1968-05-15 |
Family
ID=74187404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB56491/66A Expired GB1113760A (en) | 1966-12-16 | 1966-12-16 | Ophthalmic composition |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU412212B2 (en) |
| GB (1) | GB1113760A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0000190A1 (en) * | 1977-07-01 | 1979-01-10 | Dr. Karl Thomae GmbH | Solutions with a local anesthetic effect. |
| EP1027015A4 (en) * | 1997-03-18 | 2001-06-27 | Miles A Galin | CONTROLLED DELIVERY OF PHARMACEUTICALS IN THE FRONT EYE |
| GB2434446A (en) * | 2006-01-25 | 2007-07-25 | Pentax Corp | Method for fluorescently staining tissue |
| US8298514B2 (en) | 2006-06-15 | 2012-10-30 | Hoya Corporation | Agent for enhancing contrast of image of fluorescent staining of lumen of digestive tract |
-
1966
- 1966-12-16 GB GB56491/66A patent/GB1113760A/en not_active Expired
- 1966-12-29 AU AU15852/66A patent/AU412212B2/en not_active Expired
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0000190A1 (en) * | 1977-07-01 | 1979-01-10 | Dr. Karl Thomae GmbH | Solutions with a local anesthetic effect. |
| EP1027015A4 (en) * | 1997-03-18 | 2001-06-27 | Miles A Galin | CONTROLLED DELIVERY OF PHARMACEUTICALS IN THE FRONT EYE |
| GB2434446A (en) * | 2006-01-25 | 2007-07-25 | Pentax Corp | Method for fluorescently staining tissue |
| GB2434446B (en) * | 2006-01-25 | 2010-09-01 | Pentax Corp | Method for fluorescently staining tissue |
| DE102007003873B4 (en) * | 2006-01-25 | 2015-08-06 | Hoya Corp. | Method for fluorescence staining and examination of tissue |
| US8298514B2 (en) | 2006-06-15 | 2012-10-30 | Hoya Corporation | Agent for enhancing contrast of image of fluorescent staining of lumen of digestive tract |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1585266A (en) | 1968-07-04 |
| AU412212B2 (en) | 1971-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI951266A0 (en) | Germicidal detergent iodine compositions with reduced detergent content | |
| RU2013129222A (en) | EYE COMPOSITIONS CONCERNING MUCOADHESIVE POLYSACCHARIDES, ABLE TO STIMULATE CORNERAL RECOVERY | |
| GB1340516A (en) | Ophthalmic solution | |
| GB1244809A (en) | Synergistic antibacterial compositions | |
| GB1113760A (en) | Ophthalmic composition | |
| ES438931A1 (en) | Compositions for treatment of cardiovascular conditions associated with overproduction of catecholamines | |
| ES8308215A1 (en) | A soft contactlens preserving composition. | |
| KR0143509B1 (en) | Topical composition | |
| GB1180615A (en) | Novel Substituted Hexahydroazepino-(4,5-b) Indoles | |
| JPH0717863A (en) | Pranoprofen eye drops | |
| GB1333906A (en) | Pharmaceutical compositions | |
| ES8502337A1 (en) | Gel-form antimycotic compositions for treating fungal infections of the buccal cavity. | |
| US3415929A (en) | Ophthalmic solution containing poly-1,3-beta-glucoside | |
| JPH1025254A (en) | Water-soluble preparation free from contraindication | |
| JPS5762218A (en) | Ophthalmic solution | |
| US3044937A (en) | Process and composition for examining eyes with fluorescent vitamin b | |
| GB797237A (en) | Composition for reducing period of anesthesia | |
| GB536247A (en) | Improvements in aerosols particularly those having germicidal, disinfecting, insecticidal, or medicinal qualities | |
| ES253169A3 (en) | Method for obtaining solubilized adrenocrome compositions (Machine-translation by Google Translate, not legally binding) | |
| ES8604246A1 (en) | alpha-acyloximino-alkane-phosphonic(and -phosphinic) acid esters, their preparation and their use in plant protection. | |
| GB1320316A (en) | Ophthalmic compositions | |
| ES356078A1 (en) | Method of Manufacture of Complex Compounds of Ferric Iron with Hydrogenated Dextran and of Complex Compounds of Ferric Iron with Hydrogenated Dextran and Sodium Citrate or Citric Acid. | |
| ES460319A1 (en) | Derivatives of quinoxaline-1,4-dioxides | |
| GB549133A (en) | Improvements connected with lawn mowers | |
| GR3018349T3 (en) | Use of naproxen as mydriatic agent. |